Related Experiment Video

Updated: Apr 25, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.3K

NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer

Victoria Anastasia Belle1, Niamh McDermott2, Armelle Meunier2

  • 1Division of International Health, Mount Sinai School of Medicine, New York, NY 10029, USA.

Nature Reviews. Urology
|August 20, 2014
PubMed

Insights

Targeting the NUMB protein offers a promising strategy for prostate cancer treatment. This approach could lead to more effective therapies and identify patients who may benefit from NOTCH pathway inhibition.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Prostate cancer remains a leading cause of cancer-related deaths in men.
  • Current treatments for prostate cancer are often insufficient and cause adverse events.
  • Targeting specific biological pathways presents an opportunity for improved therapeutic strategies.

Purpose of the Study:

  • To investigate the role of NUMB (protein numb homologue) in prostate cancer.
  • To explore NUMB as a potential therapeutic target for prostate tumors.
  • To evaluate NUMB as a biomarker for predicting response to NOTCH inhibition.

Main Methods:

  • Analysis of NUMB's role in prostate cancer cell fate regulation.
  • Investigation of the NUMB-NOTCH signaling pathway in prostate tumors.
  • Assessment of NUMB's potential as a therapeutic target and predictive biomarker.

Main Results:

  • NUMB is a key regulator of cell fate implicated in prostate cancer.
  • The NUMB-NOTCH interaction is deregulated in prostate tumors.
  • NUMB shows potential for controlling prostate tumorigenesis and guiding NOTCH inhibition therapy.

Conclusions:

  • NUMB is a critical target for developing novel prostate cancer treatments.
  • NUMB can serve as a biomarker to identify patients suitable for NOTCH-targeted therapies.
  • Targeting NUMB and the NOTCH pathway offers a more specific approach to prostate cancer management.

More Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

14.0K
Stimulation of Notch Signaling in Mouse Osteoclast Precursors08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

7.7K

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.6K
Notch Signaling Pathway03:14

Notch Signaling Pathway

4.9K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
6.4K